This year, several top-rated companies are offering great deals on gorgeous bouquets you can have delivered - and you still ...

The Royal Horticultural Society (RHS) has revealed the 10 garden plants that match Pantone's Colour of the Year 2026, Cloud ...

You've probably walked past them dozens of times. Those dusty mixing bowls tucked in the back of a cupboard, the casserole dish your grandmother used every Thanksgiving. Maybe they're stacked in a ...

Dianthus Therapeutics (DNTH) revealed a new licensing agreement with Nanjing Leads Biolabs for the global rights to DNTH212, a promising autoimmune disease treatment, outside Greater China. The FDA ...

Dianthus Therapeutics (NASDAQ:DNTH) announced a licensing deal worth up to $1B with Nanjing Leads Biolabs on Thursday to obtain exclusive rights to an autoimmune disease therapy developed by the ...

Dianthus Therapeutics is offering Nanjing Leads Biolabs up to $1 billion biobucks for licensing rights to a bispecific antibody designed to treat certain autoimmune disorders. Under the terms of the ...

Green tea and matcha come from the same plant and share many benefits. One is not necessarily healthier than the other, though matcha may be slightly richer in nutrients due to its processing. Matcha ...

Dianthus Therapeutics’ generalised myasthenia gravis (gMG) asset, claseprubart, has met its primary and secondary endpoints in a Phase II trial, meaning the US biotech will progress the candidate to ...

Dianthus Therapeutics Inc. (NASDAQ:DNTH) released topline data from the Phase 2 MaGic trial evaluating the safety and efficacy of claseprubart (DNTH103) in adults with acetylcholine receptor ...